Alprazolam tablets are indicated for the: acute treatment of generalized anxiety disorder (GAD) in adults. treatment of panic disorder (PD), with or without agoraphobia in adults.
From the U.S. FDA-approved label for Alprazolam. Full label: DailyMed.
Alprazolam tablets are indicated for the: acute treatment of generalized anxiety disorder (GAD) in adults. treatment of panic disorder (PD), with or without agoraphobia in adults.
From the U.S. FDA-approved label for Alprazolam. Full label: DailyMed.
Generalized Anxiety Disorder: Recommended starting oral dosage is 0.25 mg to 0.5 mg three times daily. Dosage may be increased, at intervals of every 3 to 4 days, to a maximum recommended daily dose of 4 mg, given in divided doses. Use the lowest possible effective dose and frequently assess the need for continued treatment.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Alprazolam is contraindicated in patients: with known hypersensitivity to alprazolam or other benzodiazepines. Angioedema has been reported. taking strong cytochrome P450 3A (CYP3A) inhibitors (e.g., ketoconazole, itraconazole), except ritonavir Known hypersensitivity to alprazolam or other benzodiazepines. Concomitant use with strong cytochrome P450 3A (CYP3A) inhibitors, except ritonavir.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Effects on Driving and Operating Machinery: Patients receiving alprazolam should be cautioned against operating machinery or driving a motor vehicle, as well as avoiding concomitant use of alcohol and other central nervous system (CNS) depressant drugs. Patients with Depression: Exercise caution in patients with signs or symptoms of depression. Prescribe the least number of tablets feasible to avoid intentional overdosage. Neonatal Sedation and Withdrawal Syndrome: Alprazolam use during pregnancy can result in neonatal sedation and/or neonatal withdrawal.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following clinically significant adverse reactions are described elsewhere in the labeling: Risks from Concomitant Use with Opioids Abuse, Misuse, and Addiction Dependence and Withdrawal Reactions Effects on Driving and Operating Machinery Patients with Depression Neonatal Sedation and Withdrawal Syndrome Risks in Patients with Impaired Respiratory Function The most common adverse reactions reported in clinical trials for…
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
681 products from 370 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Alprax 0.25mg Tablet | Alprazolam (0.25mg) | Torrent Pharmaceuticals Ltd. | |
| Alprax 0.5mg Tablet | Alprazolam (0.5mg) | Torrent Pharmaceuticals Ltd. | |
| Alprazone 0.25mg Tablet | Alprazolam (0.25mg) | Ozone Pharmaceuticals Ltd. | |
| Alproz 0.25 0.25mg Tablet | Alprazolam (0.25mg) | Mark Ltd. | |
| Alproz 0.5 0.5mg Tablet | Alprazolam (0.5mg) | Mark Ltd. | |
| Alrest 0.25 0.25mg Tablet | Alprazolam (0.25mg) | Panas Pharmaceutical Pvt. Ltd. | |
| Alrest 0.5 0.5mg Tablet | Alprazolam (0.5mg) | Panas Pharmaceutical Pvt. Ltd. | |
| Alzolam 0.25mg Tablet | Alprazolam (0.25mg) | Sun Pharmaceutical Industries Ltd. | |
| Alzolam 0.5mg Tablet | Alprazolam (0.5mg) | Sun Pharmaceutical Industries Ltd. | |
| Anxit 0.25mg Tablet | Alprazolam (0.25mg) | Micro Labs Ltd. | |
| Anxit 0.5mg Tablet | Alprazolam (0.5mg) | Micro Labs Ltd. | |
| Anxit SR 0.5 Tablet | Alprazolam (0.5) | Micro Labs Ltd. | |
| Anxyl 0.25 0.25mg Tablet | Alprazolam (0.25mg) | Apex Pharmaceuticals Pvt. Ltd. | |
| Anzolam 0.25 0.25mg Tablet | Alprazolam (0.25mg) | Vijayadeep Laboratories Pvt. Ltd. | |
| Anzolam 0.5 0.5mg Tablet | Alprazolam (0.5mg) | Vijayadeep Laboratories Pvt. Ltd. | |
| Benzolam 0.25mg Tablet | Alprazolam (0.25mg) | Quest Pharmaceuticals Pvt. Ltd. | |
| Benzolam 0.5mg Tablet | Alprazolam (0.5mg) | Quest Pharmaceuticals Pvt. Ltd. | |
| Bliz 0.25 0.25mg Tablet | Alprazolam (0.25mg) | S.R. Drug Laboratories Pvt. Ltd. | |
| Bliz 0.5 0.5mg Tablet | Alprazolam (0.5mg) | S.R. Drug Laboratories Pvt. Ltd. | |
| Bliz 1mg Tablet | Alprazolam (1mg) | S.R. Drug Laboratories Pvt. Ltd. | |
| Paaz 2.5mg Tablet | Alprazolam (2.5mg) | Nepal Pharmaceuticals Pvt. Ltd. | |
| Paaz 5mg Tablet | Alprazolam (5mg) | Nepal Pharmaceuticals Pvt. Ltd. | |
| Restyl 0.25mg Tablet | Alprazolam (0.25mg) | Cipla Ltd. | |
| Restyl 0.5mg Tablet | Alprazolam (0.5mg) | Cipla Ltd. | |
| Restyl 1mg Tablet | Alprazolam (1mg) | Cipla Ltd. | |
| Restyl SR 0.5mg Tablet | Alprazolam (0.5mg) | Cipla Ltd. | |
| Rezolam 0.25 0.25 Tablet | Alprazolam (0.25) | Curex Pharmaceuticals Pvt. Ltd. | |
| Rezolam 0.50 0.50 Tablet | Alprazolam (0.50) | Curex Pharmaceuticals Pvt. Ltd. | |
| Synozolam 0.25mg Tablet | Alprazolam (0.25mg) | Synokem Pharmaceuticals Ltd | |
| Synozolam 0.5mg Tablet | Alprazolam (0.5mg) | Synokem Pharmaceuticals Ltd |
Showing 30 of 681 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Store at 20° to 25°C (68° to 77°F). Dispense contents in a tight, light-resistant container as defined in the USP with a child-resistant closure. KEEP OUT OF THE REACH OF CHILDREN.
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.